Biosency
Biosency
HQRemote
Team SizeUnknown
Open JobsUnknown
Total Funding-
Latest FundraiseUnknown
Headquarters & founding: Founded July 2017 in Rennes (Cesson-Sévigné), France
Core product: Clinically-validated remote monitoring & predictive platform for respiratory insufficiency (Bora care®, Bora connect®, BVS³ score)
Regulatory milestones: MDR certification (June 2023) and interoperability/security certification (Dec 2023)
Recent funding: Most recent disclosed round Nov 8, 2023 led by GO CAPITAL
Remote patient monitoring and predictive care for respiratory insufficiency (e.g., COPD exacerbation detection).
2017
Medtech / Digital Health
Most recent disclosed round reported Nov 8, 2023.
“Backed by a small group of investors including GO CAPITAL and Crédit Agricole Ille et Vilaine Expansion”